Logo image of AMBA

AMBARELLA INC (AMBA) Stock Fundamental Analysis

USA - NASDAQ:AMBA - KYG037AX1015 - Common Stock

72.88 USD
-11.4 (-13.53%)
Last: 10/10/2025, 9:09:53 PM
72.69 USD
-0.19 (-0.26%)
After Hours: 10/10/2025, 9:09:53 PM
Fundamental Rating

5

Taking everything into account, AMBA scores 5 out of 10 in our fundamental rating. AMBA was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While AMBA has a great health rating, there are worries on its profitability. AMBA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AMBA was profitable.
AMBA had a positive operating cash flow in the past year.
AMBA had negative earnings in each of the past 5 years.
AMBA had a positive operating cash flow in each of the past 5 years.
AMBA Yearly Net Income VS EBIT VS OCF VS FCFAMBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

With a Return On Assets value of -12.55%, AMBA is not doing good in the industry: 76.79% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -15.37%, AMBA is doing worse than 72.32% of the companies in the same industry.
Industry RankSector Rank
ROA -12.55%
ROE -15.37%
ROIC N/A
ROA(3y)-17.32%
ROA(5y)-13.28%
ROE(3y)-20.64%
ROE(5y)-15.87%
ROIC(3y)N/A
ROIC(5y)N/A
AMBA Yearly ROA, ROE, ROICAMBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

AMBA has a better Gross Margin (59.82%) than 85.71% of its industry peers.
AMBA's Gross Margin has been stable in the last couple of years.
AMBA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y0.84%
AMBA Yearly Profit, Operating, Gross MarginsAMBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMBA has more shares outstanding than it did 1 year ago.
AMBA has more shares outstanding than it did 5 years ago.
AMBA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMBA Yearly Shares OutstandingAMBA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AMBA Yearly Total Debt VS Total AssetsAMBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

AMBA has an Altman-Z score of 14.21. This indicates that AMBA is financially healthy and has little risk of bankruptcy at the moment.
AMBA has a Altman-Z score of 14.21. This is amongst the best in the industry. AMBA outperforms 80.36% of its industry peers.
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.21
ROIC/WACCN/A
WACC11.58%
AMBA Yearly LT Debt VS Equity VS FCFAMBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

AMBA has a Current Ratio of 2.73. This indicates that AMBA is financially healthy and has no problem in meeting its short term obligations.
AMBA has a Current ratio (2.73) which is comparable to the rest of the industry.
A Quick Ratio of 2.46 indicates that AMBA has no problem at all paying its short term obligations.
AMBA has a Quick ratio (2.46) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.46
AMBA Yearly Current Assets VS Current LiabilitesAMBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

AMBA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 148.35%, which is quite impressive.
The Revenue has grown by 57.91% in the past year. This is a very strong growth!
AMBA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.49% yearly.
EPS 1Y (TTM)148.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%215.38%
Revenue 1Y (TTM)57.91%
Revenue growth 3Y-4.97%
Revenue growth 5Y4.49%
Sales Q2Q%15.56%

3.2 Future

Based on estimates for the next years, AMBA will show a very strong growth in Earnings Per Share. The EPS will grow by 78.65% on average per year.
The Revenue is expected to grow by 21.05% on average over the next years. This is a very strong growth
EPS Next Y396.6%
EPS Next 2Y124.27%
EPS Next 3Y85.65%
EPS Next 5Y78.65%
Revenue Next Year36.08%
Revenue Next 2Y21.23%
Revenue Next 3Y19.26%
Revenue Next 5Y21.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMBA Yearly Revenue VS EstimatesAMBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AMBA Yearly EPS VS EstimatesAMBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 165.64, AMBA can be considered very expensive at the moment.
AMBA's Price/Earnings is on the same level as the industry average.
AMBA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.02.
The Price/Forward Earnings ratio is 141.51, which means the current valuation is very expensive for AMBA.
Based on the Price/Forward Earnings ratio, AMBA is valued a bit more expensive than 63.39% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AMBA to the average of the S&P500 Index (22.57), we can say AMBA is valued expensively.
Industry RankSector Rank
PE 165.64
Fwd PE 141.51
AMBA Price Earnings VS Forward Price EarningsAMBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

AMBA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 84.13
EV/EBITDA N/A
AMBA Per share dataAMBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMBA's earnings are expected to grow with 85.65% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y124.27%
EPS Next 3Y85.65%

More info and screens

0

5. Dividend

5.1 Amount

AMBA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBARELLA INC

NASDAQ:AMBA (10/10/2025, 9:09:53 PM)

After market: 72.69 -0.19 (-0.26%)

72.88

-11.4 (-13.53%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-28 2025-08-28/amc
Earnings (Next)11-25 2025-11-25/amc
Inst Owners87.33%
Inst Owner Change-0.7%
Ins Owners2.8%
Ins Owner Change-0.79%
Market Cap3.11B
Analysts76.19
Price Target91.78 (25.93%)
Short Float %4.87%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)178.3%
Min EPS beat(2)173.6%
Max EPS beat(2)183%
EPS beat(4)4
Avg EPS beat(4)332.47%
Min EPS beat(4)173.6%
Max EPS beat(4)763.65%
EPS beat(8)8
Avg EPS beat(8)179.99%
EPS beat(12)12
Avg EPS beat(12)131.37%
EPS beat(16)16
Avg EPS beat(16)100.86%
Revenue beat(2)2
Avg Revenue beat(2)2.33%
Min Revenue beat(2)0.64%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)3.19%
Min Revenue beat(4)0.64%
Max Revenue beat(4)5.55%
Revenue beat(8)5
Avg Revenue beat(8)4.97%
Revenue beat(12)5
Avg Revenue beat(12)2.72%
Revenue beat(16)6
Avg Revenue beat(16)1.75%
PT rev (1m)0%
PT rev (3m)17.68%
EPS NQ rev (1m)7.82%
EPS NQ rev (3m)262.72%
EPS NY rev (1m)332.37%
EPS NY rev (3m)332.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)8.57%
Valuation
Industry RankSector Rank
PE 165.64
Fwd PE 141.51
P/S 8.94
P/FCF 84.13
P/OCF 59.42
P/B 5.4
P/tB 5.86
EV/EBITDA N/A
EPS(TTM)0.44
EY0.6%
EPS(NY)0.52
Fwd EY0.71%
FCF(TTM)0.87
FCFY1.19%
OCF(TTM)1.23
OCFY1.68%
SpS8.15
BVpS13.5
TBVpS12.44
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.55%
ROE -15.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.82%
FCFM 10.63%
ROA(3y)-17.32%
ROA(5y)-13.28%
ROE(3y)-20.64%
ROE(5y)-15.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y0.84%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 57.6%
Cap/Sales 4.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.46
Altman-Z 14.21
F-Score5
WACC11.58%
ROIC/WACCN/A
Cap/Depr(3y)54.66%
Cap/Depr(5y)54.82%
Cap/Sales(3y)4.47%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)148.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%215.38%
EPS Next Y396.6%
EPS Next 2Y124.27%
EPS Next 3Y85.65%
EPS Next 5Y78.65%
Revenue 1Y (TTM)57.91%
Revenue growth 3Y-4.97%
Revenue growth 5Y4.49%
Sales Q2Q%15.56%
Revenue Next Year36.08%
Revenue Next 2Y21.23%
Revenue Next 3Y19.26%
Revenue Next 5Y21.05%
EBIT growth 1Y39.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-312.48%
EBIT Next 3Y72.92%
EBIT Next 5Y59.62%
FCF growth 1Y218.82%
FCF growth 3Y-6.94%
FCF growth 5Y-9.01%
OCF growth 1Y99.07%
OCF growth 3Y-4.46%
OCF growth 5Y-3%